🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Hematopoietic Cell Transplant

Assessing Pulmonary Changes in HSCT NCT07823036Phase 1, Phase 21 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: Hyperpolarized 129 Xenon Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation NCT05335434NA1 site📍 Boston Dana-Farber Cancer Institute · Tests: THOR LX2.3 with LED Lollipop Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy NCT04056533Phase 21 site📍 Santander Instituto de Investigación Marqués de Valdecilla · Tests: CMV CTLs Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors NCT02508038Phase 11 site📍 Madison University of Wisconsin, Madison · Tests: TCRαβ+/CD19+ depleted Haploidentical HSCT, Zoledronate Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation. NCT07670468Phase 1, Phase 21 site📍 Seoul LucasBio · Tests: LB-DTK-MV CMV-CMI in csCMVi After HSCT NCT07688759n/a1 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: Anti-Cytomegalovirus Therapy Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT NCT06946654n/a1 site📍 Beijing Peking University People's Hospital · Tests: Geriatric Assessment Safety and Efficacy Study of Transplantation of Autologous CD34+ Cells Transduced With the G2ARTE Lentiviral Vector Expressing the DCLRE1C cDNA in Artemis (DCLRE1C) Deficient Severe Combined Immunodeficiency Patients (ARTEGENE) NCT05071222Phase 1, Phase 21 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: ARTEGENE drug product Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma NCT06245629n/a1 site📍 Uppsala Uppsala University · Tests: Bortezomib-bendamustine-melphalan Early De-escalation of Empirical Antibiotics Treatment for Neutropenic Fever NCT04270786NA1 site📍 Shanghai Shanghai Jiao Tong University School of Medicine · Tests: Early de-escalation, Standard Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant NCT06996119Phase 11 site📍 Duarte City of Hope Medical Center · Tests: Biospecimen Collection, Busulfan, Computed Tomography, Cyclophosphamide, Echocardiography Test Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen NCT06532084Phase 21 site📍 Saint Petersburg St. Petersburg State Pavlov Medical University · Tests: Sorafenib Study of a Cohort of Non-HIV Immunocompromised Patients With Toxoplasmosis at the Strasbourg University Hospital NCT07299500n/a1 site📍 Strasbourg University Hospital, Strasbourg, France Haploidentical Hematopoietic Stem Cell Transplantation With Early ATG and Low Dose Post-transplant Cyclophosphamide NCT06041893n/a1 site📍 Seoul Samsung Medical Center · Tests: ATG-LDPTCy CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia NCT06633328EARLY Phase 11 site📍 Hanzhou Zhejiang University · Tests: CD7 CAR-T cells injection, Allogeneic hematopoietic stem cell transplantation Prehabilitation for Patients Diagnosed With Blood Cancer and Treated With Al-logeneic Hematopoietic Stem Cell Transplantation NCT07341698NA1 site📍 Copenhagen Copenhagen University Hospital, Rigshospitalet · Tests: Resistance training, Nutritional Support, Usual care Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy NCT06895538Phase 2, Phase 31 site📍 Beijing Peking University First Hospital · Tests: Rabbit Anti-Human T-Lymphocyte Immunoglobulin (ATLG) Nutrition OUtReach In Systems of Healthcare NCT06802406NA4 sites📍 Stanford📍 Fairway📍 New York University of Kansas Medical Center · Tests: Food Bags Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation NCT06138587Phase 12 sites📍 Boston📍 Boston Dana-Farber Cancer Institute · Tests: Cytokine Induced Memory-like Natural Killer Cells, Interleukin-2 Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation NCT06028828Phase 21 site📍 Orange University of California, Irvine · Tests: Fludarabine, Melphalan, Total Body Irradiation Study of a Copaiba-Based Mouthwash Combined With Low-Level Laser Therapy in the Prevention of Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation NCT07810530Phase 21 site📍 Rio de Janeiro Instituto Nacional de Cancer, Brazil · Tests: Copaíba, Placebo Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplantation NCT06916195n/a5 sites📍 Genova📍 Monza📍 Padova MSD Italia S.r.l. Single Arm Study of Post-transplant Azacitidine and Chidamide for Prevention of Acute Myelogenous Leukemia Relapse NCT05270200Phase 1, Phase 21 site📍 Guanzhou Zhujiang Hospital · Tests: Azacitidine, Chidamide Biomarkers Impact Evaluation on the Post-transplant Immune Response After Allografting of Hematopoietic Stem Cells NCT04517656NA1 site📍 Saint-Etienne Centre Hospitalier Universitaire de Saint Etienne · Tests: Blood samples Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia NCT06581081NA1 site📍 Beijing Peking University People's Hospital · Tests: Senl_B19 autologous CAR-T (S1904) treatment Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML NCT07304232Phase 25 sites📍 Shijiazhuang📍 Harbin📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Chidamide A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System® NCT02007356Phase 21 site📍 Basel University Hospital, Basel, Switzerland · Tests: IFN-γ positive selected T-cells Psychosocial and Behavioral Intervention for Stem Cell Transplant Patients and Their Family Caregivers NCT07107165NA1 site📍 Pittsburgh University of Pittsburgh · Tests: Dyadic Problem Solving Training, Supportive Care The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of Anti-HLA Antibodies Prior to Allo-HSCT NCT06362967Phase 21 site📍 Hefei Anhui Provincial Hospital · Tests: Immunoadsorption or plasma exchange combined with rituximab, high-dose IVIG Enhanced Molecular Microbiological Surveillance Versus Ceftriaxone Prophylaxis in Hematopoietic Cell Transplant Patients NCT07308457NA1 site📍 Szczecin Pomeranian Medical University Szczecin · Tests: Ceftriaxone 1000 MG
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy